Halozyme Therapeutics, Inc.

LPL Financial LLC HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

210,320

Value ($000)

14,155

Weight

0.0%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	14,155	0.0%	210,320	12/31/2025
2025 Q3	11/12/2025	14,297	0.0%	194,944	9/30/2025
2025 Q2	8/12/2025	11,597	0.0%	222,938	6/30/2025
2025 Q1	5/7/2025	15,470	0.0%	242,432	3/31/2025
2024 Q4	2/11/2025	9,897	0.0%	207,003	12/31/2024
2024 Q3	11/8/2024	8,677	0.0%	151,593	9/30/2024
2024 Q2	8/7/2024	6,013	0.0%	114,831	6/30/2024
2024 Q1	5/10/2024	2,243	0.0%	55,130	3/31/2024
2023 Q4	2/14/2024	1,756	0.0%	47,501	12/31/2023
2023 Q3	11/13/2023	1,647	0.0%	43,120	9/30/2023
2023 Q2	7/31/2023	1,384	0.0%	38,382	6/30/2023
2023 Q1	5/10/2023	1,156	0.0%	30,268	3/31/2023
2022 Q4	2/7/2023	1,126	0.0%	19,786	12/31/2022
2022 Q3	11/14/2022	588	0.0%	14,882	9/30/2022
2022 Q2	8/12/2022	726	0.0%	16,497	6/30/2022
2022 Q1	5/16/2022	577	0.0%	14,456	3/31/2022
2021 Q4	2/14/2022	989	0.0%	24,589	12/31/2021
2021 Q3	11/15/2021	704	0.0%	17,318	9/30/2021
2021 Q2	8/13/2021	797	0.0%	17,556	6/30/2021
2021 Q1	5/14/2021	645	0.0%	15,476	3/31/2021
2020 Q4	2/12/2021	448	0.0%	10,486	12/31/2020
2020 Q3	11/9/2020	263	0.0%	10,002	9/30/2020
2020 Q2	8/13/2020	1,010	0.0%	37,676	6/30/2020